Literature DB >> 22122223

Intensifying treatment of type 2 diabetes mellitus: adding insulin.

Kyle R Peters1.   

Abstract

Treatment for patients with type 2 diabetes mellitus is typically initiated with a combination of lifestyle modification and oral drugs. This treatment provides sustained glycemic control in some patients, but many others require administration of insulin as their disease progresses and pancreatic β cells are lost. One of the most important points in long-term care for patients with type 2 diabetes is the transition to insulin therapy. Health care professionals must choose the most appropriate insulin preparations for management of patients with type 2 diabetes who cannot achieve treatment goals by using other therapies. These include basal, premixed, and basal-bolus insulin regimens. In addition, there are multiple approaches to initiation of insulin treatment, including addition of basal insulin to oral drugs, switching patients to a premixed insulin formulation, or basal-bolus treatment. The pharmacist can play a key role in the transition to insulin therapy by providing education and assisting in day-to-day management of patients with type 2 diabetes who require insulin for intensification of treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22122223     DOI: 10.1592/phco.31.12.54S

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  2 in total

1.  High mobility group box 1 (HMGB1) mediates high-glucose-induced calcification in vascular smooth muscle cells of saphenous veins.

Authors:  Yongyi Wang; Jianggui Shan; Wengang Yang; Hui Zheng; Song Xue
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 2.  Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin.

Authors:  Anja Schweizer; James E Foley; Wolfgang Kothny; Bo Ahrén
Journal:  Vasc Health Risk Manag       Date:  2013-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.